- E74.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E74.02 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E74.02 – other international versions of ICD-10 E74.02 may differ.
ICD-10-CM E74.02 is grouped within Diagnostic Related Group(s):
- 642 Inborn and other disorders of metabolism
Applicable To
- Cardiac glycogenosis
- Type II glycogen storage disease
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E74.02:
- glycogen > Cardiomegaly
- cardiac glycogenosis > due to I42.6
- glycogen storage > Cardiomyopathy (familial) (idiopathic) I42.9
- lysosomal alpha-1, 4 glucosidase > Deficiency, deficient
- heart > glycogen storage E74.00
- myocardium > glycogen storage E74.00
- Pompe\’s > glycogen storage E74.00
- type II > glycogen storage E74.00
- glycogen storage > heart (organic) I51.9
- Pompe\’s (glycogenosis II) > Disease, diseased
- cardiac > Glycogenosis (diffuse) (generalized)
- glycogenic > cardiac
- glycogenic > heart, cardiac
- glycogenic > myocardium, myocardial
- glycogen storage > Myocardiopathy (congestive) (constrictive) (familial) (hypertrophic nonobstructive) (idiopathic) (infiltrative) (obstructive) (primary) (restrictive) (sporadic) I42.9
- cardiac glycogenosis > in (due to) E51.12